Public opinion
Peppies commissioned Mason-Dixon Polling & Strategy - one of the most-cited independent polling firms in the country - to field a national survey on what Americans actually think about peptides, legal access through licensed pharmacies, the unregulated grey market, and trust in the FDA and the pharmaceutical industry.
The questionnaire is finalized and the survey is heading to field. Topline results, full crosstabs, and a downloadable summary will be published here when the data is in.
Whether adults should be able to get peptides legally, through a licensed U.S. pharmacy with a prescription.
How many would seek peptides from other sources if they couldn't get them legally - and how many have already had a bad reaction from a non-pharmacy source.
How much Americans trust the FDA to put patients ahead of pharmaceutical-industry interests.
Whether peptides should come only from large drug companies, or also from licensed compounding pharmacies.
Whether the health system should prioritize preventing illness or treating it after the fact.
How many would submit a public comment if a federal agency opened one on peptide access.
